Trends of Primary Renal Tumors in Adult Pakistani Population. A Single Center Study

Mariam  Fatima; Kanwal  Babar; Hira  Batool; Rafeya  Yasin; Omar  Chughtai; Azra  Bashir

doi:10.54112/bcsrj.v6i6.1867

Authors

Mariam Fatima Department of Histopathology, Chughtai Institute of Pathology, Lahore, Pakistan
Kanwal Babar Department of Histopathology, Chughtai Institute of Pathology, Lahore, Pakistan
Hira Batool Department of Histopathology, Chughtai Institute of Pathology, Lahore, Pakistan
Rafeya Yasin Department of Histopathology, Chughtai Institute of Pathology, Lahore, Pakistan
Omar Chughtai Department of Histopathology, Chughtai Institute of Pathology, Lahore, Pakistan
Azra Bashir Department of Histopathology, Chughtai Institute of Pathology, Lahore, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v6i6.1867

Keywords:

Clear Cell RCC, Papillary RCC, Chromophobe RCC, Oncocytoma

Abstract

Renal cell carcinoma (RCC) represents a heterogeneous group of tumors with diverse histopathological subtypes and clinical behaviors. Locoregional studies are essential to understand various subtypes, prevalence, demographic patterns, and staging profiles for effective disease management. Objective: The purpose of this study is asses the histological spectrum, demographic characteristics, and pathological staging of renal tumors diagnosed at a specialized diagnostic center in Pakistan. Methods: A cross-sectional analysis was conducted at Chughtai Lab from March 2023 to September 2024. A total of 267 cases of renal tumors, including both malignant and benign entities, were reviewed. Tumors were classified according to the 2022 WHO Classification. Pathological staging was performed using the AJCC 8th edition TNM system. Data were analyzed using SPSS v26.0, with descriptive statistics for frequency, percentage, and mean age calculations. Results: Clear cell RCC is the most prevalent subtype (61.79%), followed by papillary RCC (8.61%) and chromophobe RCC (4.86%). Rare malignant tumors account for 5.61% of cases. Among benign tumors, oncocytoma is the most common (4.1%). The mean age of patients is 53.8 years, with a male-to-female ratio of 1.47:1. Pathological staging reveals pT1b (30.00%) followed by pT3a (22.91%) and pT2a (20.83%) are the most frequent stages among 240 patients. Conclusion: Clear cell RCC remains the predominant renal tumor subtype in our population. Most cases are diagnosed at early pathological stages, indicating improved detection trends. This study contributes essential locoregional data that support global epidemiological patterns and highlights the importance of accurate histopathological classification for optimal patient management.

Downloads

Download data is not yet available.

References

Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J, et al. Epidemiology of renal cell carcinoma. Eur Urol. 2023;83(2):227-41. https://doi.org/10.1016/j.eururo.2018.08.036

Uchendu IK, Tchawe YS, Sangadzhieva ZD, Rusanov AS, Bagmet LN, Sanikovich VD, Nikitina NM, Ikebunwa OA, Okoroiwu HU, Kazeem OB, Sekacheva MI. Epidemiology Patterns of Renal Cell Carcinoma Worldwide: Examining Risk Factors and Contemporary Immunotherapy Approaches. https://doi.org/10.20944/preprints202310.1757.v1

Scelo G, Larose TL. Epidemiology and risk factors for kidney cancer. J Clin Oncol. 2020;38(30):2910-26. https://doi.org/10.1200/JCO.2018.79.1905

Shaikh H, Jamal SZ, Mahmood SF. Ashraf S, Parveen S, Ashraf S, Sultana M, Ishaque U, Shafqat Z, Shabbir S, Riaz Z, Faiz Z. Coronavirus epidemiology, diagnosis, and vaccination statistics in Pakistan, China, and India: A brief review. Current Trends in OMICS. 2024 Mar 5;4(1):95-116. https://doi.org/10.32350/cto.41.06

Aijaz P, Baloch KF, Faiz H, Durvesh AK, Tirmizi SJ, Khan M, Sohail H, Khalid S, Niazi MA, Kamran A, Niazi MA. Clinical presentation, tumor characteristics, and management of intradiverticular transitional cell carcinoma of the urinary bladder: a systematic review. Cureus. 2024 Jun 23;16(6). https://doi.org/10.7759/cureus.62974

Raj RK, Upadhyay R, Wang SJ, Singer EA, Dason S. Incorporating stereotactic ablative radiotherapy into the multidisciplinary management of renal cell carcinoma. Current Oncology. 2023 Dec 1;30(12):10283-98. https://doi.org/10.3390/curroncol30120749

Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, Fernández-Pello S, Giles RH, Hofmann F, Hora M, Klatte T, Kuusk T, Lam TB, Marconi L, Powles T, Tahbaz R, Volpe A, Bex A. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022 Oct;82(4):399-410. doi: 10.1016/j.eururo.2022.03.006. Epub 2022 Mar 26. PMID: 35346519. https://doi.org/10.1016/j.eururo.2022.03.006

Abushamma F, Barqawi A, Al-Jabi SW, Akkawi M, Maree M, Zyoud SE. Global analysis of research trends on kidney function after nephron-sparing surgery: a bibliometric and visualised study. Cancer Management and Research. 2021 Sep 27:7479-87. https://doi.org/10.2147/CMAR.S324284

Kuthi L. Clinicopathological Features of the Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification (Doctoral dissertation, University of Szeged (Hungary).

Albasri AM, El-Siddig AA, Hussainy AS, Alhujaily AS. Clinicopathologic Patterns of Adult Renal Tumors. Saudi J Med Med Sci. 2017 Sep-Dec;5(3):242-247. doi: 10.4103/sjmms.sjmms_87_16. Epub 2017 Aug 21. https://doi.org/10.4103/sjmms.sjmms_87_16

Wang R, Wolf JS Jr, Wood DP Jr, Higgins EJ, Hafex KS(2009). Accuracy of percutaneous core biopsy in management of small renal masses. Urology, 73|, 586-90. https://doi.org/10.1016/j.urology.2008.08.519

Bhatta RR, Pandey G, Bastakoti S, Dhungana I, Upreti S, Jha NK. Histopathological pattern of adult renal tumours in a tertiary cancer center. J Pathol Nep 2022;12(1):1929-32. DOI:10.3126/ jpn.v12i1.41857. https://doi.org/10.3126/jpn.v12i1.41857

Bloise F, Manfredi F, Zatteri L, Dima G, Carli C, Di Vita R, Olivieri M, Sammarco E, Ferrari M, Salfi A, Bonato A. First-line treatments and Management of Metastatic Renal Cell Carcinoma Patients: an Italian interdisciplinary Uro-oncologic group algorithm. Cells. 2024 Jun 2;13(11):961. https://doi.org/10.3390/cells13110961

latte T, Patard JJ, Goel RH, et al. Prognostic impact of tumor size on pT2 RCC. J Urol. 2007;178(1):35–40. https://doi.org/10.1016/j.juro.2007.03.046

Frank I, Blute ML, Cheville JC, et al. Mayo Clinic SSIGN score for ccRCC. Cancer. 2002;94(10):2597–2604

Frequency, Clinical Presentation and Evolution of Renal Oncocytomas: Multicentric Experience from a European Database Romis, Leo et al. European Urology, Volume 45, Issue 1, 53 – 57. https://doi.org/10.1016/j.eururo.2003.08.008

Rajagopal R, Yoztyurk E, Ravendran K (October 16, 2024) Renal Oncocytoma: A Systematic Review of Its Metastatic Features. Cureus 16(10): e71649. doi:10.7759/cureus.71649. https://doi.org/10.7759/cureus.71649

Hollingsworth JM, Miller DC, et al. Small renal masses: treatment effect. J Natl Cancer Inst. 2006;98(18):1331–1334. https://doi.org/10.1093/jnci/djj362

Alaghehbandan R, Siadat F, Trpkov K. What's new in the WHO 2022 classification of kidney tumours? Pathologica. 2022 Feb;115(1):8-22. doi: 10.32074/1591-951X-818. Epub 2023 Jan 16. PMID: 36645398; PMCID: PMC10342217. https://doi.org/10.32074/1591-951X-818

Thompson RH, Ordonez MA, Iasonos A, et al (2008). Renal Cell Carcinoma in young and old patients is there a difference ? J Urol, 180, 1262-6. https://doi.org/10.1016/j.juro.2008.06.037

Latif F, Mubarak M, Kazi JI. Histopathological characteristics of adult renal tumours: a preliminary report. J Pak Med Assoc. 2011 Mar;61(3):224-8. PMID: 21465932.

22. Experience with renal cell carcinoma- a single centre study from khyber pakhtunkhwa Haroon Sabir Khan, Junaid Mansoor, Sohail Sabir, Arshad Mahmood Pak Armed Forces Med J 2017; 67 (4): 513-17

Znaor A, Lortet-Tieulent J, et al. Global trends in RCC incidence and mortality. Eur Urol. 015;67(3):519–530. https://doi.org/10.1016/j.eururo.2014.10.002

Epidemiology of Renal Cell Carcinoma: 2022 Update, Bukavina, Laura et al. European Urology, Volume 82, Issue 5, 529 – 542. https://doi.org/10.1016/j.eururo.2022.08.019

Sun M, Thuret R, Abdollah F, et al. RCC incidence and mortality in North America. Eur Urol. 2011;59(1):135–141. https://doi.org/10.1016/j.eururo.2010.10.029

Srivastava A, Mandhani A, Kapoor R, Jain M, Dubey D, Srivastava A, et al. Prognostic factors in renal cell carcinoma: is TNM (1997) staging relevant in Indian subpopulation? Indian J Cancer 2004; 41: 99-103.

Hashmi AA, Ali R, Hussain ZF, Faridi N. Clinicopathologic patterns of adult renal tumors in Pakistan. Asian Pac J Cancer Prev. 2014;15(5):2303-7. doi: 10.7314/apjcp.2014.15.5.2303. PMID: 24716974. https://doi.org/10.7314/APJCP.2014.15.5.2303

Bocardo Fajardo G, Arnellano GerianR, Gonzelez Lopez L, et al (2009). Prognostic significance of the microscopic invasion of renal vein wall in RCC. Arch Esp Urol

Hank R, Bui MH, Pantuck AJ, et al (2003). TNM T3a renal cell carcinoma, Adrenal gland is not the same as renal fat invasion. J Urol, 169, 899-3. https://doi.org/10.1097/01.ju.0000051480.62175.35

Thompson RH, Hill JR, et al. RCC metastatic risk by tumor size. J Urol. 2009;182(1):41–5. https://doi.org/10.1016/j.juro.2009.02.128